[1] World Health Organization. Global Health Observatory. Geneva: World Health Organization. who.int/gho/database/en/. Accessed May 14, 2019. 2018.
[2] Ministry of Health RI. Infodatin: Stop Cancer, Center for Data and Information Ministry of Health, (online).(accessible 14-05-2019). 2018.
[3] Avendaño, C.; Menéndez, J.C. Drug targeting in anticancer chemotherapy. Med. Chem. Anticancer Drugs. 2015, 595-653.
[4] Barosi, G.; Besses, C.; Birgegard, G.; Briere, J.; Cervantes, F.; Finazzi, G.; Gisslinger, H.; Griesshammer, M.; Gugliotta, L.; Harrison, C.; Hasselbalch, H.; Lengfelder, E.; Reilly, J.T.; Michiels, J.J.; Barbui, T. A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group. Leukemia. 2007, 21, 277-280.
[5] Tibes, R.; Mesa, R.A. Blood consult: resistant and progressive essential thrombocythemia. Blood. 2011, 118, 240-242.
[6] McCarthy, A.R.; Pirrie, L.; Hollick, J.J.; Ronseaux, S.; Campbell, J.; Higgins, M.; Staples, O.D.; Tran, F.; Slawin, A.M.Z.; Lain, S.; Westwood, N.J. Synthesis and biological characterisation of sirtuin inhibitors based on the tenovins. Bioorg. Med. Chem. 2012, 20, 1779-1793.
[7] Widiandani T.; Arifianti L.; Siswandono. Docking, Synthesis, and Cytotoxicity Test Human Breast Cancer Cell Line T47D of N-(Allylcarbamothioyl)benzamide, Int. J. Pharm. Clin. 2016, 8, 372-376.
[8] Kesuma, D.; Siswandono., Purwanto, B.; T., Rudyanto, M. Synthesis of N-(phenylcarbamothioyl)-benzamide derivatives and their cytotoxic activity against MCF-7 cells. J. Chin. Pharm. Sci. 2018. 27, 696-702.
[9] Siswandono, Development of New Drugs. Surabaya: Airlangga University Press. 2014.
[10] Kar, A. Medicinal Chemistry, 4th ed. New Delhi: New Age International Ltd Publishers. 2007, 794-810.
[11] Kesuma, D.; Siswandono.; Purwanto, B.T.; Rudyanto, M. Docking, Synthesis and Cytotoxic Test On Human Breast Cancer Cell Line T47D of N-(Phenylcarbamothioyl)-benzamide. World J. Pharm. Res. 2018, 7, 70-78.
[12] Cancer Chemoprevention Research Center Faculty of Pharmacy UGM (CCRC-UGM), Fixed procedure Cytotoxic Test Method MTT. 2012.
[13] Manual Software Molegro Virtual Docker. http://www. molegro/mvd-technology.php. downloaded 7/8/2015. 2011.
[14] Li, H.Q.; Yan, Y.; Shi, L.; Zhou, C.F.; Zhu, H. Synthesis and structure-activity relationships of N-benzyl-N-(X-2-hydroxybenzyl)-N′-phenylureas and thioureas as antitumor agents. Bioorg. Med. Chem. 2010, 18, 305-313.
[15] Huhtiniemi, T.; Suuronen, T.; Rinne, V.M.; Wittekindt, C.; Lahtela-Kakkonen, M.; Jarho, E.; Wallén, E.A.A.; Salminen, A.; Poso, A.; Leppänen, J. Oxadiazole-carbonylaminothioureas as SIRT1 and SIRT2 inhibitors. J. Med. Chem. 2008, 51, 4377-4380.
[16] Clayden, J.; Greeves, N.; Warren, S.; Wothers, P. Organic Chemistry, 2nd ed. New York: Oxford University Press. 2012, 279-289.
[17] McMurry, J.M. Fundamental of Organic Chemistry, 7th ed., Belmont: Brooks/Cole. 2011, 349.
[18] Pavia, D.L.; Lampman, G.M.; Kriz, G.S.; James R.; Vyvyan, J.R. Spectroscopy. 4th ed. Belmont: Brooks/Cole. 2009, 851-886.
[19] Song, D.Q.; Du, N.N.; Wang, Y.M.; He, W.Y.; Jiang, E.Z.; Cheng, S.X.; Wang, Y.X.; Li, Y.H.; Wang, Y.P.; Li, X.; Jiang, J.D. Synthesis and activity evaluation of phenylurea derivatives as potent antitumor agents. Bioorg. Med. Chem. 2009, 17, 3873-3878.
[20] Hinchliffe, A. Molecular Modelling for Beginners, 2nd ed., Chichester: John Wiley and Sons Ltd. 2008. |